AMA PRA Category 1 Credit

Efficacy and Safety of Oral PCSK9 Inhibitor Enlicitide in Adults With Heterozygous Familial Hypercholesterolemia

Importance  Persons with heterozygous familial hypercholesterolemia (HeFH) are at increased risk of atherosclerotic cardiovascular disease due to lifelong elevated levels of low-density lipoprotein cholesterol (LDL-C). Many patients with HeFH do not achieve guideline-recommended LDL-C goals with the currently available lipid-lowering therapies….

Coronary Computed Tomography Angiography in Prediction of First Coronary Events

Importance  Risk stratification strategies in primary prevention of coronary events lack precision. Objective  To determine whether prediction of first coronary events is improved by adding information on coronary atherosclerosis from coronary computed tomography angiography (CCTA) to a model using the pooled cohort…

Primary Biliary Cholangitis

This JAMA Insights discusses the clinical presentation, diagnosis, and treatment of primary biliary cholangitis.

Metabolic Dysfunction–Associated Steatotic Liver Disease in Adults

Importance  Metabolic dysfunction–associated steatotic liver disease (MASLD) includes a range of liver conditions, progressing from isolated steatosis (characterized by fat accumulation in the liver without inflammation) to metabolic dysfunction–associated steatohepatitis (MASH), which involves fat accumulation and inflammation in the liver. The…

An AI-Powered Lifestyle Intervention vs Human Coaching in the Diabetes Prevention Program – A Randomized Clinical Trial

Importance  Prediabetes is common, yet evidence-based lifestyle interventions are underutilized. Objective  To determine whether referral to an exclusively artificial intelligence (AI)–led lifestyle intervention based on the Diabetes Prevention Program (DPP) is noninferior to referral to a human-led DPP in achieving recommended thresholds…